Timmerman, John M.
Cleveland Clinic · The University of Texas MD Anderson Cancer Center · University of Miami · University of California, Los Angeles · Moffitt Cancer Center · Dana-Farber Cancer Institute · The Ohio State University
6 papers on CoChatORCID 0000-0003-4104-8943
Most cited papers
- Verified
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 6,030
- Verified
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Locke, F. L., Ghobadi, A., Jacobson, C. A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., et al. (2019) · The Lancet Oncology
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,286
- Verified
KTE-X19 CAR T cell therapy in relapsed or refractory mantle-cell lymphoma
Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., Timmerman, J. M., Holmes, H., Jaglowski, S., Flinn, I. W., et al. (2020) · New England Journal of Medicine
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 1,862
- Verified
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment
Cited by 1,001
- Verified
Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients
Hurvitz, S. A., Betting, D. J., Stern, H. M., Quinaux, E., Stinson, J., Seshagiri, S., Zhao, Y., Buyse, M., Mackey, J., Driga, A., et al. (2012) · Clinical Cancer Research
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 115
- Verified
Antibody-Cytokine Fusion Proteins for Treatment of Cancer: Engineering Cytokines for Improved Efficacy and Safety
Young, P. A., Morrison, S. L., & Timmerman, J. M. (2014) · Seminars in Oncology
Monoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and Immunotoxins
Cited by 66
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free